The VEGF‐Mediated Cytoprotective Ability of MIF‐Licensed Mesenchymal Stromal Cells in House Dust Mite‐Induced Epithelial Damage. [[{“value”:”Hazel Dunbar, Ian J. Hawthorne, Courteney Tunstead, Molly Dunlop, Evelina Volkova, Daniel J. Weiss, Claudia C. dos Santos, Michelle E. Armstrong, Seamas C. Donnelly, Karen English”}]]
Licensing of MSCs with MIF requires CXCR4 receptor binding. Enhanced VEGF production by MIF-licensed MSCs promotes wound healing in vitro and can be blocked using the VEGFR2 inhibitor SU-5416. MIF-licensed MSC conditioned medium significantly reduced goblet cell hyperplasia in house dust mite-driven allergic airway inflammation in vivo. ABSTRACT Enhancing mesenchymal stromal cell (MSC) therapeutic efficacy … Read more